Electromed Inc (ELMD)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $188.82M
Last updated: Nov 17, 2026 at 4:15 PM ET
Electromed Inc (ELMD) Statistics
Electromed (ELMD) has a market cap of $188.82M and an enterprise value of $172.94M. Its trailing P/E of 16.8x is below its 10-year median of 27.3x.
Total Valuation
Enterprise value is 8.41% below the market cap, as cash exceeds debt.
| Market Cap | $188.82M |
|---|---|
| Enterprise Value | $172.94M |
| Latest price (Nov 17, 2026) | $23.11 |
Key Dates
The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | June |
Valuation Ratios
Sales and book value multiples are 2.5x and 3.7x. Its year-end P/E ranged from 20.1x to 59.1x from 2016 to 2025.
| P/E Ratio | 16.8x |
|---|---|
| Forward P/E | 15.6x |
| P/S Ratio | 2.5x |
| Forward P/S | 2.3x |
| P/B Ratio | 3.7x |
| P/TBV Ratio | 3.7x |
| P/FCF Ratio | 22.1x |
| P/OCF Ratio | 19.1x |
| PEG Ratio | 0.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.2x EBITDA and 20.2x free cash flow.
| EV / Earnings | 14.5x |
|---|---|
| EV / Sales | 2.3x |
| EV / EBITDA | 11.2x |
| EV / FCF | 20.2x |
Price Statistics
The stock is down 8.57% over 52 weeks and trades 14.50% below its 50-day average.
| Beta (1Y) | 0.70 |
|---|---|
| 52-Week Change | -8.57% |
| 1-Month Change | -15.68% |
| 3-Month Change | -43.47% |
| 6-Month Change | -39.78% |
| 5-Year Change | +146.27% |
| 10-Year Change | +564.37% |
| Total Return (1Y) | -8.57% |
| Total Return (3Y CAGR) | +30.06% |
| Total Return (5Y CAGR) | +14.39% |
| Return vs SPY (1Y) | -17.33% |
| Max Drawdown (1Y) | -50.12% |
| Max Drawdown (3Y) | -50.12% |
| Sharpe Ratio (1Y) | -0.12 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $27.03 |
| 200-Day Average | $31.12 |
| 52-Week Range | $22.67 to $47.40 |
| RSI (14 Days) | 25.7 |
| Average Volume (20 Days) | 51.95K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 7.19x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 7.19x |
|---|---|
| Quick Ratio | 6.66x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 22.73% over the last 12 months, against a 5-year average of 13.02%.
| Return on Equity (ROE) | 22.73% |
|---|---|
| Return on Assets (ROA) | 19.52% |
| ROE (5Y Average) | 13.02% |
| ROA (5Y Average) | 10.68% |
| ROIC (5Y Average) | 18.31% |
| Asset Turnover | 1.32x |
| Inventory Turnover | 4.24x |
| Receivables Turnover | 2.52x |
| Cash Conversion Cycle | 174 days |
Taxes
Income tax took 21.50% of pretax income over the last 12 months.
| Income Tax (TTM) | $3.27M |
|---|---|
| Effective Tax Rate | 21.50% |
Scores
ELMD has an Altman Z-Score of 16.89, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 16.89 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $75.57M over the last 12 months is up 14.12% from the 12 months before.
| Revenue | $75.57M |
|---|---|
| Revenue Growth (YoY) | +14.12% |
| Gross Profit | $59.68M |
| Operating Income | $14.70M |
| Pretax Income | $15.19M |
| Net Income | $11.93M |
| EBITDA | $15.78M |
| Reported EPS (TTM) | $1.38 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 85.89% of the $61.09M in total assets.
| Cash and Equivalents | $15.88M |
|---|---|
| Total Debt | $0 |
| Net Cash | $15.88M |
| Net Cash Per Share | $1.91 |
| Working Capital | $44.93M |
| Shareholder Equity | $52.47M |
| Book Value Per Share | $6.32 |
| Tangible Book Value | $52.09M |
| Tangible Book Per Share | $6.27 |
| Total Assets | $61.09M |
| Total Liabilities | $8.62M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.17M of capital spending, operating cash flow left $8.70M of free cash flow.
| Operating Cash Flow | $9.87M |
|---|---|
| Capital Expenditures | $1.17M |
| Free Cash Flow | $8.70M |
| FCF Per Share | $1.05 |
| Depreciation and Amortization | $1.08M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 19.45%, against a 5-year average of 12.28%.
| Gross Margin | 78.98% |
|---|---|
| Operating Margin | 19.45% |
| Pretax Margin | 20.10% |
| Net Margin | 15.78% |
| EBITDA Margin | 20.88% |
| FCF Margin | 11.52% |
| Gross Margin (5Y Average) | 76.87% |
| Operating Margin (5Y Average) | 12.28% |
| Net Margin (5Y Average) | 9.73% |
Growth
Revenue grew 15.35% a year over 3 years, and EPS 53.71% a year.
| Revenue Growth (3Y CAGR) | +15.35% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.59% |
| EPS Growth (3Y CAGR) | +53.71% |
| EPS Growth (5Y CAGR) | +38.13% |
| FCF Growth (5Y CAGR) | +24.70% |
| Operating Income Growth (3Y CAGR) | +51.30% |
Dividends and Yields
ELMD does not pay a dividend. Its free cash flow yield is 4.53%.
| Earnings Yield | 5.95% |
|---|---|
| FCF Yield | 4.53% |
| Buyback Yield | 3.77% |
| Shareholder Yield | 3.77% |
Peer Position
Against 12 similar companies, ELMD has the 4th highest P/S.
P/S RatioPeer median 1.3x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +5.66%
| P/S Ratio | 2.5x vs 1.3x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +14.12% vs +5.66% median |
Analyst Forecast
Consensus estimates put revenue growth at 11.24% and EPS growth at 13.36% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +11.24% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +13.36% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ELMD
What is ELMD's market cap?
Electromed has a market cap of $188.82M. Its enterprise value, which adds debt and subtracts cash, is $172.94M.
What is ELMD's P/E ratio?
Electromed has a trailing P/E ratio of 16.8x and a forward P/E of 15.6x.
How many shares of ELMD are outstanding?
Electromed has 8.31M shares outstanding. The count is down 0.19% from a year earlier.
Does ELMD pay a dividend?
No. Electromed does not pay a dividend.
How much debt does ELMD have?
Electromed has $0 of total debt and $15.88M of cash and equivalents, a net cash position of $15.88M.
ELMD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors